The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.

Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.

Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.

Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.

Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.

A Urine Pregnancy Test (UPT) detects the presence of the hormone hCG in a woman’s urine to confirm pregnancy.

You can take a UPT if you have missed your period or are experiencing early pregnancy symptoms.

The UPT is highly accurate when performed correctly and can detect pregnancy within a few days of a missed period.

The test involves collecting a urine sample and using a test strip or device to detect hCG levels.

If your UPT result is positive, contact your healthcare provider to discuss the next steps and begin prenatal care.

Knowing your blood group is crucial for safe blood transfusions, organ transplants, and managing pregnancies to prevent Rh incompatibility.

No, the Blood Group Test does not detect diseases. It only determines your blood type and Rh factor.

No, fasting is not required. You can eat and drink normally before the test.

A healthcare provider draws a blood sample from your vein, which is then analyzed in a laboratory to determine your blood type.

Results are typically available within a few hours after the blood sample is collected and analyzed.